QIM
REGN icon

Quest Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Quest Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-6,999
Closed -$2.41M – 111
2018
Q1 		$2.41M Buy
6,999
+42
+0.6% +$14.6K 0.37% 61
2017
Q4 		$2.62M Sell
6,957
-25,445
-79% -$10.3M 0.39% 58
2017
Q3 		$14.5M Buy
32,402
+13,111
+68% +$6.24M 1.86% 21
2017
Q2 		$9.47M Buy
+19,291
New +$8.44M 1.26% 41
2016
Q1 		– Sell
-12,436
Closed -$6.75M – 110
2015
Q4 		$6.75M Sell
12,436
-3,229
-21% -$1.75M 0.92% 41
2015
Q3 		$7.29M Buy
15,665
+2,546
+19% +$1.37M 1.02% 43
2015
Q2 		$6.69M Buy
13,119
+569
+5% +$278K 0.94% 43
2015
Q1 		$5.67M Sell
12,550
-5,020
-29% -$2.13M 0.77% 55
2014
Q4 		$7.21M Sell
17,570
-20,631
-54% -$8.11M 0.86% 48
2014
Q3 		$13.8M Buy
38,201
+8,996
+31% +$3.02M 1.45% 10
2014
Q2 		$8.25M Buy
29,205
+28,435
+3,693% +$8.43M 0.81% 45
2014
Q1 		$231K Buy
+770
New +$237K 0.02% 208

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Quest Investment Management's REGN Position: Q2 2018 in Review

Quest Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q2 2018, closing a stake of 6,999 shares — an estimated $2.41M sold.

Quest Investment Management first reported a position in REGN in Q1 2014 and held it in 12 quarters. The position peaked at $14.5M in Q3 2017. 624 funds tracked by Wall St. Rank hold REGN as of Q2 2018.

  • Quest Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Quest Investment Management sold 6,999 Regeneron Pharmaceuticals shares in Q2 2018, an estimated $2.41M.
  • Quest Investment Management first reported a position in Regeneron Pharmaceuticals in Q1 2014 and held it in 12 quarters.
  • Quest Investment Management's Regeneron Pharmaceuticals position peaked at $14.5M in Q3 2017.
  • 624 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2018.

Based on Quest Investment Management's 13F filing for Q2 2018, filed 6 Aug 2018.